Alan Wisee
Vorstandsvorsitzender bei Duke Street Bio Ltd.
Profil
Alan Wisee is currently the Chief Executive Officer & Director at Duke Street Bio Ltd.
He previously held the position of Chief Executive Officer at IOmet Pharma Ltd.
and Chairman at Cumulus Oncology Ltd.
Aktive Positionen von Alan Wisee
| Unternehmen | Position | Beginn |
|---|---|---|
Duke Street Bio Ltd.
 Duke Street Bio Ltd. BiotechnologyHealth Technology Duke Street Bio Ltd. is a British precision medicine company that targets specific genetic alterations in cancer using a DDR vulnerability approach. The company is based in London, UK. The company's goal is to deliver life-saving cancer treatments to improve patient outcomes. The company was founded in 2020. The CEO is Alan Wisee. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Alan Wisee
| Unternehmen | Position | Ende |
|---|---|---|
IOmet Pharma Ltd.
 IOmet Pharma Ltd. Drugstore ChainsRetail Trade IOmet Pharma Ltd. develops drugs and related products. It focuses on developing the novel ideas sourced from universities, research institutes and industry as well as internally generated programs. The company was founded by Peter Trill and Tom Brown in 2010 and is headquartered in Scotland, the United Kingdom. | Vorstandsvorsitzender | 16.07.2018 |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
IOmet Pharma Ltd.
IOmet Pharma Ltd. Drugstore ChainsRetail Trade IOmet Pharma Ltd. develops drugs and related products. It focuses on developing the novel ideas sourced from universities, research institutes and industry as well as internally generated programs. The company was founded by Peter Trill and Tom Brown in 2010 and is headquartered in Scotland, the United Kingdom. | Retail Trade |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
Duke Street Bio Ltd.
Duke Street Bio Ltd. BiotechnologyHealth Technology Duke Street Bio Ltd. is a British precision medicine company that targets specific genetic alterations in cancer using a DDR vulnerability approach. The company is based in London, UK. The company's goal is to deliver life-saving cancer treatments to improve patient outcomes. The company was founded in 2020. The CEO is Alan Wisee. | Health Technology |
